Phenotype of BTK ‐lacking myeloid cells during prolonged COVID ‐19 and upon convalescent plasma
European Journal of Haematology(2022)
摘要
XLA patient with 7-month course of COVID-19 with persistent plasma SARS-CoV-2 load revealed a sustained non-inflammatory profile of myeloid cells in association with contained severity of disease, arguing in favor of the use of BTK inhibitors in SARS-COV-2 infection.
更多查看译文
关键词
BTK,COVID-19,SARS-CoV-2,X-linked agammaglobulinemia,innate immunity,monocytes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要